TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the way in which TD-1211 is absorbed and eliminated
by the body and to evaluate whether it is safe and well tolerated.
Phase:
Phase 1
Details
Lead Sponsor:
Theravance Biopharma Theravance Biopharma R & D, Inc.